The new products and growth sectors driving America’s long-term winners
Felix Wintle, manager of the VT Tyndall North American Fund, highlights three favourite US stocks where he'd put his money
Our investment process focuses on companies that are growing revenue, margins and earnings. When you find these three factors accelerating at the same time, there is a good chance you have a stock that’s going to perform well. We often find that companies with these characteristics are at the beginning of a new product cycle, and much of our stock analysis is concentrated on finding those companies.
We marry our fundamental work with macroeconomic analysis, which helps us identify where we are in the business cycle. This informs our risk appetite: aggressive in bull markets, defensive in bear markets. Finally, we use technical analysis to time our buys and sells.
Our style is active, and we like to find stocks exhibiting strong share price momentum, showing that the market validates our fundamental views. In constructing our portfolio, we apply a split approach – core stock selection based on finding long-term thematic winners, and tactical selection driven by the outlook for growth and inflation.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The resulting portfolio tends to vary significantly from both the index and our peer group. We believe that the following three stocks boast considerable upside potential.
Two top investment themes
Palantir (Nasdaq: PLTR) is at the centre of two of the biggest investment themes of today, namely defence and AI. It is a software developer embedded with organisations such as the CIA and the US military, enabling them to interpret and use the huge amounts of data they receive on a daily basis.
Palantir also has commercial applications and helps companies optimise their supply chains and other operational functions. The company is unique in that it doesn’t have any true competitors in terms of the product suite it provides. It is growing revenue at an annual pace of 55% and looks set to continue its strong performance.
Axon Enterprises (Nasdaq: AXON) is the company formerly known as Taser, and it still makes the iconic Taser product. Its mission is to dramatically reduce the number of deaths by firearms, and it has done that over the years as its non-lethal alternative has gained traction globally. It also has a bodycam product, which is where the real potential lies. The bodycam videos the arrests of suspects, and then Axon’s AI software takes the footage and writes up reports for police officers. This saves an average of four hours of police time a day and is one of the few real-world applications of AI today. Axon’s penetration of global markets is still in the single digits, and we believe it can continue its 27% top-line growth.
More bang for the buck
We believe that Dollar General (NYSE: DG) is in the early stages of a big turnaround. The main reason for this is that one of its competitors in the dollar-store sector, Family Dollar, is closing stores at a rapid rate, and in doing so, it is donating market share to Dollar General. Its last earnings call gave this thesis a boost – the company reported accelerating revenue and margins, and the stock jumped 16%.
Concerns over tariffs and household spending have been priced into this stock, in our view, and with the company trading at 0.4 times sales, it is cheap and primed for a rerating.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Felix has managed the VT Tyndall North American Fund since July 2017 when he joined Tyndall Investment Management. He began his career in September 1999 at City Financial Asset Management, becoming manager of the CF Biotech Fund in 2003. In 2004, the firm was acquired by Neptune Investment Management and he took over management of the Neptune US Opportunities Fund in August 2005, which he ran until May 2016.
-
The most influential people of 2025Here are the most influential people of 2025, from New York's mayor-elect Zohran Mamdani to Japan’s Iron Lady Sanae Takaichi
-
Millions of parents are missing out on up to £720 a year in extra pension cash – are you affected?A mum who narrowly missed out on the pension boost said she “never knew the government rule existed” and wants other parents to use it
-
Stock markets have a mountain to climb: opt for resilience, growth and valueOpinion Julian Wheeler, partner and US equity specialist, Shard Capital, highlights three US stocks where he would put his money
-
Goodwin: A superlative British manufacturer to buy nowVeteran engineering group Goodwin has created a new profit engine. But following its tremendous run, can investors still afford the shares?
-
A change in leadership: Is US stock market exceptionalism over?US stocks trailed the rest of the world in 2025. Is this a sign that a long-overdue shift is underway?
-
Profit from document shredding with RestoreRestore operates in a niche, but essential market. The business has exciting potential over the coming years, says Rupert Hargreaves
-
New frontiers: the future of cybersecurity and how to investMatthew Partridge reviews the key trends in the cybersecurity sector and how to profit
-
Three solid British stocks going cheapOpinion Ian Lance and Nick Purves, fund managers at Temple Bar Investment Trust, highlight three British stocks with strong cash flows and robust balance sheets
-
Is now a good time to invest in Barclays?Barclays' profit growth is healthy, and the stock is cheap compared with its rivals
-
Profit from other investors’ trades with CME GroupCME Group is one of the world’s largest exchanges, which gives it a significant competitive advantage
